Health care startups that raised Series A in Guangdong, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Aibo Medical Robot | Shenzhen | Series A | $14.1M | 2026-10-15 |
| Artivila Therapeutics | Shenzhen | Series A | $14.7M | 2026-06-23 |
| Shanmu SHANMU | Shenzhen | Series A | $14.7M | 2026-05-06 |
| Ningkang Ruizhu | Zhuhai | Series A | $14.1M | 2025-12-05 |
| PulseCare | Shenzhen | Series A | $14.0M | 2025-11-06 |
| Liying Bio | Shenzhen | Series A | $13.7M | 2024-12-31 |
| Travention | Guangzhou | Series A | $1.4M | 2024-08-18 |
| Baikuirui | Shenzhen | Series A | $1.4M | 2024-04-23 |
8 rows of the CSV in 5 of its 18 columns.
- The 199 health care startups in Guangdong, China whose last round is Series A have raised $1.3B in total.
- 33 of them closed their most recent round in the last 12 months, $228.8M combined.
- The largest of those rounds is PAM2L Biotechnologies' $30.0M Series A, dated October 2026.
- The most recent is Libo Biotech's $15.0M Series A on 30 October 2026.
- Shenzhen Capital Group is an investor in 4 of them, more than any other fund.
- Biotech is the most common other sector, with 54 companies (27%).
- 24% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (45% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 199| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| Ningkang Ruizhu | Ningkang Ruizhu develops targeted drugs. | Biotech | Zhuhai | Series A | $14.1M | 2025-12-05 | $25.6M | GF Qianhe Investment, RiverHead Capital, Hanne Capital +1 | 11 to 50 | 2019 |
| PulseCare | PulseCare is a medtech company that makes medical devices for cardiac and pan-vascular treatment. | Health care | Shenzhen | Series A | $14.0M | 2025-11-06 | $28.1M | Delian Capital, Tasly Capital, Tianfeng Capital | 11 to 50 | 2021 |
| Yuanyi Biotech | Yuanyi Biotech creates artificial microbial technologies and products. | Biotech | Tianjin | Series A | $13.7M | 2023-10-18 | $21.5M | Marathon Venture Partners, Haitang Fund, Ruipeng Touzi | 51 to 100 | 2021 |
| YORKTAL | YORKTAL develops digital medical imaging software. | Health care | Futian | Series A | $1.5M | 2018-01-02 | $1.5M | Flyfot Ventures | 51 to 100 | 2011 |
| iCarbonX Unicorn | iCarbonX is a China-based company that builds artificial intelligence platforms for health data. | Artificial intelligence | Shenzhen | Series A | $45.0M | 2016-07-15 | $200.0M | Share Capital, ProCapital | 51 to 100 | 2015 |
Table 1. Health care startups that raised Series A in Guangdong, China: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 199.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| 2 | Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| 3 | Ningkang Ruizhu | Ningkang Ruizhu develops targeted drugs. | Biotech | Zhuhai | Series A | $14.1M | 2025-12-05 | $25.6M | GF Qianhe Investment, RiverHead Capital, Hanne Capital +1 | 11 to 50 | 2019 |
| 4 | Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 |
Table 2. Health care startups that raised Series A in Guangdong, China: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 4 | 2% | ||
| 2 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 2 | 1% | 1 | Aibo Medical Robot |
| 3 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 2 | 1% | 1 | Aibo Medical Robot |
| 4 | SZHTI Group | Venture capital firm | Shenzhen, China | 2 | 1% | 2 | Newdel Biotech, JGene Biotechnology |
| 5 | EFung Capital | Private equity firm | Shenzhen, China | 2 | 1% | 1 | JGene Biotechnology |
| 6 | Tasly Capital | Corporate venture arm | Tianjin, China | 2 | 1% | ||
| 7 | Haitang Fund | Venture capital firm | Nankai, China | 2 | 1% | ||
| 8 | Kaitai Capital | Venture capital firm | Hangzhou, China | 2 | 1% | ||
| 9 | Lingdu Capital | Private equity firm | Wuhan, China | 2 | 1% | ||
| 10 | Chang'an Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | Aibo Medical Robot |
| 11 | Alwin Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | Aibo Medical Robot |
| 12 | Long Hill Capital | Venture capital firm | Shanghai, China | 1 | 1% | 1 | Aibo Medical Robot |
| 13 | Guangzhou Finance Holdings | Private equity firm | Guangzhou, China | 1 | 1% | 1 | MingCeler |
| 14 | Highlight Capital | Private equity firm | Nanjin, China | 1 | 1% | 1 | Artivila Therapeutics |
| 15 | Hike Capital | Private equity firm | Beijing, China | 1 | 1% | 1 | Artivila Therapeutics |
Table 3. Health care startups that raised Series A in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series A in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 199 | 100% | $5.6M |
Table 5. Health care startups that raised Series A in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups that raised Series A in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 4 | 12% | $59.1M |
| August 2026 | 2 | 6% | $1.4M |
| July 2026 | 4 | 12% | $14.8M |
| June 2026 | 3 | 9% | $44.3M |
| May 2026 | 2 | 6% | $29.4M |
| March 2026 | 3 | 9% | $29.0M |
| February 2026 | 3 | 9% | $14.4M |
| January 2026 | 7 | 21% | $20.7M |
| December 2025 | 3 | 9% | $15.7M |
| November 2025 | 2 | 6% |
Table 7. Health care startups that raised Series A in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 28 | 14% | $213.0M |
| 2025 | 27 | 14% | $73.8M |
| 2024 | 17 | 9% | $61.4M |
| 2023 | 21 | 11% | $51.3M |
| 2022 | 13 | 7% | $188.9M |
| 2021 | 15 | 8% | $194.4M |
Table 8. Health care startups that raised Series A in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 9 | 5% |
| 2020 to 2022 | 38 | 19% |
| 2015 to 2019 | 87 | 45% |
| 2010 to 2014 | 35 | 18% |
| Before 2010 | 26 | 13% |
Table 9. Health care startups that raised Series A in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 14 | 9% |
| 11 to 50 | 68 | 45% |
| 51 to 100 | 33 | 22% |
| 101 to 250 | 16 | 11% |
| 251 to 500 | 8 | 5% |
| 501 to 1,000 | 9 | 6% |
| 1,001 to 5,000 | 2 | 1% |
| 5,001 to 10,000 | 1 | 1% |
| 10,001 or more | 1 | 1% |
Table 10. Health care startups that raised Series A in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in Guangdong, China. On 16 November 2026 that is 199 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 199 rows: 79 have no round amount, 0 no city and 77 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Guangdong, China whose last round is Series A are on the list?
- 199, in the file dated 16 November 2026. 33 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 199 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.